Structure Therapeutics Ratios (2022-2026) | GPCR

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 172.60M238.39M222.90M349.19M469.62M702.13M940.12M918.27M884.94M841.50M824.30M1,208.04M1,546.02M
Equity Average (Quarter) -84.67M-98.01M-109.53M60.61M225.38M203.69M322.96M441.39M675.42M908.92M880.82M844.74M798.36M771.05M1,143.20M1,481.74M
Invested Capital (Quarter) -77.23M-92.10M-103.91M-115.14M236.35M214.41M192.96M452.97M429.82M921.03M896.80M864.84M824.64M772.08M770.02M1,516.38M1,447.09M
Leverage & Solvency
Equity Ratio (Quarter) -1.180.960.930.890.940.940.970.960.960.950.950.930.960.96
Valuation
Enterprise Value (Quarter) -90.84M-349.07M-224.59M-205.42M-467.32M-775.02M-1472.59M-1648.22M-1589.34M-1508.69M-786.50M-1487.68M-1446.20M-2600.84M
Return Ratios
Return on Capital Employed (Quarter) -36.67%-31.91%-41.78%-31.68%-25.81%-18.02%-15.68%-2.91%-5.89%-10.85%-15.00%-2.58%-4.20%
Return on Invested Capital (Quarter) 0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%